fda approves first oral glp-1 obesity drug august 14 2025 Foundayo (orforglipron) – Non-Peptide RA FDA-approved April 2026 for chronic weight management. Once-daily tablet with no fasting requirement, stepwise dosing up to 17.2 mg, and meaningful weight reduction in The Age of Oral GLP-1s

An analysis of a community-driven reconstruction of the human metabolic network

Taking high-dose supplements over 1,000 mg per day may also increase the risk of kidney stones in predisposed people ( Benefits of Supplements There is mixed evidence that vitamin C supplements benefit people who get adequate amounts from the diet

Argireline Argireline targets expression lines by relaxing muscle signaling

(01:25:18) Movement in the Workspace (01:31:00) Summary & Shifting Work Environments (01:39:36) Zero-Cost Support, Sponsors, Instagram, Twitter, Supplements Title Card Photo Credit: Mike Blabac Disclaimer Day 57 Using Play to Rewire & Improve Your Brain | Episode 58 In this episode, I discuss the transformative nature of playhow it changes our feelings, thoughts and actions and indeed, how it can rewire our brain to function better in all contexts

Legal Disclaimer For external use only

Wegovy (semaglutide) was only recently approved by the FDA for weight management in individuals with obesity or overweight, weight gain, and at least one weight-related health condition